Literature DB >> 14600598

Molecular mechanisms of bone metastasis and therapeutic implications.

Regis J O'Keefe1, Theresa A Guise.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14600598     DOI： 10.1097/01.blo.0000093847.72468.2f

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  11 in total

1.  Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.

Authors:  Amjad Javed; George L Barnes; Jitesh Pratap; Tomasz Antkowiak; Louis C Gerstenfeld; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

Review 2.  Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer.

Authors:  Aaron M LeBeau; Maya Kostova; Charles S Craik; Samuel R Denmeade
Journal:  Biol Chem       Date:  2010-04       Impact factor: 3.915

3.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  A Case of Carcinoid Tumor-Associated Hypercalcemia.

Authors:  Fadi Siyam; Obai Abdullah; Michael Gardner; Stephen Brietzke; James Sowers
Journal:  Cardiorenal Med       Date:  2012-01-26       Impact factor: 2.041

5.  Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.

Authors:  Maya B Kostova; D Marc Rosen; Ying Chen; Ronnie C Mease; Samuel R Denmeade
Journal:  J Med Chem       Date:  2013-06-04       Impact factor: 7.446

Review 6.  Therapy for osteosarcoma: where do we go from here?

Authors:  Alexander J Chou; David S Geller; Richard Gorlick
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

7.  Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.

Authors:  Yi Lu; Qiuyan Chen; Eva Corey; Wen Xie; Jie Fan; Atsushi Mizokami; Jian Zhang
Journal:  Clin Exp Metastasis       Date:  2008-11-11       Impact factor: 5.150

8.  Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.

Authors:  D J Leeming; M Koizumi; P Qvist; V Barkholt; C Zhang; K Henriksen; I Byrjalsen; M A Karsdal
Journal:  Biomark Cancer       Date:  2011-03-03

9.  Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.

Authors:  Tae-kyung Kwak; Eun Jung Sohn; Sunhee Kim; Gunho Won; Jeong-Un Choi; Kwon Jeong; Myoungseok Jeong; Oh Sung Kwon; Sung-Hoon Kim
Journal:  BMC Complement Altern Med       Date:  2014-10-27       Impact factor: 3.659

10.  Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

Authors:  Bhavik Desai; Michael J Rogers; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2007-03-07       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.